Pulmonary Substudy: A Substudy of Strategic Timing of AntiRetroviral Treatment (START) [Substudy of profile 700040645]
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Antiretrovirals
- Indications HIV infections
- Focus Pharmacodynamics
- Acronyms START
- 01 Nov 2019 Biomarkers information updated
- 29 Oct 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Sep 2013 Accrual to date is 102% according to United Kingdom Clinical Research Network.